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2020 has been blighted by a global pandemic for which the outcome and extent for all of us is 
still unknown.  However, even the most difficult of times can offer the opportunity to learn and 
grow.  NIADA were gifted such an opportunity by Queens University’s Centre of Evidence and 
Social Innovation (CESI).  The opportunity to take a snapshot in time and record the behaviour 
and trends of a range of service users, across Northern Ireland, who were participating in the 
substance use services and interventions of NIADA members.   
Thanks to CESI this short survey has provided NIADA with a range of valuable information 
upon which members, policy makers, influencers and others can utilise to plan and improve 
services as we strive to meet service users complex and diverse needs post-COVID.   
This vital information could not be more timely as the Department of Health, responsible for 
leading and co-ordinating action on Northern Ireland’s new substance use strategy, issue 
‘Making Life Better – Preventing Harm and Empowering Recovery: A Strategic 
Framework to Tackle the Harm from Substance Use’ for public consultation. The first 
critical review in nearly 10 years.  
I wish to thank all those who took part in this survey, particularly the service users. I commend 
the NIADA members for committing to the process and for reviewing and commenting on this 
report during a very trying and stressful time for their staff.  I am extremely grateful for all your 
efforts and applaud you all for stepping up and standing out. 
NIADA’s services users experience and feedback, documented in this report, will galvanise 
NIADA’s resolve to ensure the right services are available throughout Northern Ireland, in the 
right place, at the right time. 
 
Anne-Marie McClure 








The Northern Ireland Alcohol and Drugs Alliance (NIADA) is a group of voluntary and 
community sector organisations that provide support to those affected by alcohol and drug 
use, and their families. Their members include organisations that provide a range of services 
to children, young people, individuals and their families. Organisations vary in size and focus. 
Larger organisations for example, deliver many services, with drugs and alcohol being only 
one of many aspects of provision. Specific organisations may focus primarily on the needs of 
children and young people, including their mental health and overall wellbeing. Smaller 
organisations may focus more on drugs and alcohol (or other addiction) related need.  
Importantly, NIADA facilitates a coordinated approach for all these organisations to raise 
awareness and influence policy and practice on the impact of alcohol and drug use on 
individuals, families and communities. 
As part of the public health response to the Covid-19 pandemic, stringent restrictions on 
physical contact introduced by the government, required organisations to reduce one to one 
contact to a minimum. For drug and alcohol services, this meant putting in place emergency 
response plans to ensure that service user needs continued to be met. This often called for 
evolving news ways of working to comply with national guidance while maintaining 
communication. Among the challenges for service organisations was the unparalleled nature 
of Covid-19, the fact that no examples of good practice existed and determining how people 
experiencing issues related to alcohol or drugs were being affected by the health pandemic.  
Organisations recognised the need to better understand how their service users were being 
impacted by coronavirus. For example, ASCERT conducted a survey in April 2020, with plans 
to follow-up in May (ASCERT, 2020). A co-ordinated effort was made by NIADA to gather 
information across their organisations that would augment what was already known. Queen’s 
University Belfast assisted NIADA with their work.  
Sincere appreciation and thanks goes to everyone who took the time to complete the 
questionnaire and to the organisations that participated in the research. 
NIADA survey  
 
A short survey was distributed by NIADA in mid-May 2020, asking organisations to encourage 
their clients to participate. This was when lockdown was fully in place. The survey aimed to 
build on the important information that had already been collected by ASCERT. In addition to 
the survey, organisational leads were asked to maintain a diary over a four to six week period 
(from late May to the end of June 2020), noting their observations, thoughts on whether and 
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how Covid-19 was impacting on people’s experience of drug and alcohol use and noting 
anything of concern/interest/change in patterns of use. To avoid placing additional work 
burdens on organisations, diaries were deliberately short and concise, with people recording 
their reflections in the way that suited them best.  
Five organisations kept diary entries during this time. As noted above, these organisations 
vary in size and focus. The diaries revealed some common themes that aligned with 
information revealed in the survey. When considered alongside the survey results, the diaries 
provide additional context in relation to the experiences of individuals, their families and 
service providers during this period.  
Demographic information 
 
A total of 149 people took part in the survey. Over two-thirds of respondents were male (64%). 
This is broadly reflective of published information on people presenting to services with 
problem drug and/or alcohol use where the majority of clients were male (DoH, 2019).  
The age of people who responded to the survey ranged between 14 years and 71 years of 
age (see Figure 1). Fifteen percent were under the age of 18 years, which is higher than 
numbers usually recorded in official statistics. This is likely to be reflective of the range of 
services offered by individual organisations who engaged with the study and the higher 
likelihood that younger people were in contact with these organisations. 



















Pattern of use 
 
Of the 149 respondents, 17 did not report substance use at the time of the survey, the majority 
of which were young respondents (aged under 18). More than half of those taking part 
indicated that alcohol was their main substance (58%).   
 
Table 1: Main substance used 
Main substance (n) % 
Alcohol 86 58 
Benzodiazepine 6 4 
Cannabis 15 10 
Meth/Chrystal meth 2 1 
Cocaine 10 7 
Opiates (inc codeine) 3 2 
Opioids (inc heroin) 7 5 
Porn 1 1 
Pregablin 1 1 
Tobacco 1 1 
None 17 11 
 
Alcohol use was particularly high among older respondents. For those aged 46-60 years, more 
than four-fifths (83%) indicated that alcohol was their main substance. The percentage was 
even greater for those aged older than 60 years of age, with all respondents in this age group 
reporting alcohol as their main substance.  
Official statistics for the UK show a similar pattern, with increases in the frequency of alcohol 
consumption by older people (ONS, 2018). Research suggests that the interaction between 
alcohol and older people’s increasing use of multiple medicines (Moriarty et al. 2015) leaves 
them particularly vulnerable to physical and mental health harms and alcohol-specific death 
(Comiskey, 2020; Holton et al. 2017). 
Cannabis was the next most common main substance, reported by 10% of respondents. 
Again, there was an age gradient noticeable, with younger respondents more likely to report 
cannabis as their main substance. The 18-25 age group were the most likely to report mainly 
using cannabis (40%), while no one in the oldest two age groups said cannabis was their main 
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substance. Again, this is similar to other research showing increased use of cannabis among 
young adults (DoH, 2015; EMCDDA, 2019). 
People were also asked whether they used a secondary or any other substance. Over half 
(57%) did not name any other substances, other than their main substance. For the remaining 
43%, a range of other substances was mentioned, with respondents sometimes recording two, 
three or more other substances (polydrug use). Other substances mentioned included a 
mixture of prescription medication (e.g. pregablin, tramadol), opioids (e.g. codeine, fentanyl), 
cocaine, cannabis and alcohol.   
Change in use 
 
To get a picture of how and if people’s substance use habits had been affected during the time 
when lockdown restrictions were at their height, people were asked:  
‘Has your main substance use changed in the past 4 weeks?’ Responses were: 
 I’m using more 
I’m using less 
It hasn’t changed 
At the time the survey was carried out, over a third (37%) of people who named a main 
substance said they were using more, 45% said they were using less, for 18% of people it 
remained the same. See Figure Two. 
Figure 2: Main substance use in the past 4 weeks 
 
 
Of those people who were using secondary or multiple substances, a quarter (25%) said they 
were using more additional substances. Just over half (51%) were using less, with almost a 








Figure 3: Secondary substance use in the past 4 weeks 
 
The decline in substance use is similar to findings investigating the effects and implications of 
Covid-19 across European countries during the first 3 months of the pandemic (EMCDDA, 
2020). 
There was a statistically significant link between the way people were using their main and 
secondary substance - people who reported using less of their main substance, were almost 
all likely to be using less of their secondary substance/s, if they were using other substances.  
For those who were using more of their main substance, almost half (48%) were using more 
of their secondary substance too, indicating the existence of an intensified cohort of clients.  
Of those who reported using a main substance, the majority (83%) had not changed the way 
they used their substance. For the remaining 17% who said they had changed the way they 
were using their main substance, examples of change included moving from beer to spirits, 
smoking rather than sniffing (or vice versa), trying cannabis edibles, swapping smoking heroin 
for injecting. However, the numbers are very small and no main conclusions can be drawn. 
Very few people (6%) who were using additional substances had changed the way they were 
using them. 
Very few respondents had tried a new substance in the past four weeks (11%). Of those that 
had, it was mostly a different type of their usual substance – for example a different type of 
alcohol, or prescription drug or different form of the same drug, for example crack cocaine as 
opposed to cocaine. Reasons for use were mainly that their regular substance was not 
available and to try something new. Other reasons included feelings of isolation, lack of routine 
and because others were using it. Again, numbers are small and no clear patterns emerged. 











People were asked how their physical and mental health had been recently. The majority of 
respondents reported ‘good or very good’ physical health (55%). This might be due to the 
higher than usual number of younger respondents aged under 18 years, given that younger 
people were more likely to rate their physical health as good or very good. 
However, fewer people reported positive mental health; 65% said their mental health was 
‘poor or very poor’ with just over a third (35%) describing their mental health as ‘good or very 
good’. While young people under 18 years of age were the least likely to say their mental 
health had been poor, it was still the case that 39% of young people said they experienced 
poor or very poor mental health recently. 1  
 
Figure 4: Recent physical health   Figure 5: Recent mental health  
 
 
Follow up questions asked if people had received any support that helped them cope better 
with their physical and/or mental health over the past four weeks and to say where that support 
came from. Respondents could select more than one option and there was an ‘other’ category 
if support was received from a different source. Two-thirds (66%) of respondents with 
poor/very poor physical health said they received support recently that helped them cope with 
their health issues. Support came from a variety of sources, but was mainly from a medical 
professional (e.g. doctor, nurse, social worker). The next significant source of support came 
from a community/voluntary/charity organisation. Very little support came from any ‘other’ 
source, although two people added ‘personal trainer’ as an additional source.  
                                                          
1 In the ASCERT survey, 68% of respondents said their physical health had been affected ‘a little or a lot’ by the 
coronavirus pandemic, while 89% said their mental health had been affected ‘a little or a lot’ by the pandemic. 





























Most people who described their recent mental health as poor/very poor had received support 
that helped them cope better (81%). Overwhelmingly, that support came from a 
community/voluntary/charity organisation, with 70% people saying they got help from this 
source. Reliance on the voluntary and community sector (VCS) for support for mental health 
support draws attention to the dual diagnosis issues of clients and how their needs are less 
likely to be addressed within primary care or acute services. 
The next significant source of support for mental health issues came from a family member 
(36%). The findings underline the importance of the VCS and the role that family play in 
providing mental/emotional health. It also highlights the fundamental importance of sustaining 
the ability of the family to continue in their supportive role.  
A question was included at the end of the survey asking if there were other types of support 
that would have helped people cope better during this time. Just over a third of respondents 
answered this question (n=52). Comments mostly clustered around continued access to drug 
and alcohol services and better/easier access to mental health services and primary health 
services as mechanisms for helping people cope better. A summary of responses is provided 
in Table Two alongside the number of people who specifically mentioned this source of 
support (simply to indicate frequency of issues raised within comments).  
Table 2: Support to help people cope better 
Other support that would help you cope better at this time Number of people who 
said this 
Better access to mental health services/primary health services 
(e.g. GP appointments, medical consultation, access to opioid 
substance therapy) 
24 
Continued access to drug & alcohol services 18 
Financial/legal aid 5 
Help with housing issues 5 
More social contact with family and friends 3 
Help from social services 3 
Sporting activities 2 
  
Better access to mental health and primary health services during lockdown and continued 
engagement with addiction services were the main forms of support most cited as helping 
people to cope better. Difficulties getting a GP appointment or not being able to consult with a 
specialist or discuss revision of medication were among examples given. Six people 
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specifically mentioned that easier/increased access to opioid substance therapy (OST) would 
have helped them cope better during lockdown. Again, this is similar to other findings where 
clinicians in a number of European countries highlighted increases in emergency 
presentations for mental health problems (EMCDDA, 2020). 
Regarding continued engagement with substance use services, some people stated a 
preference for personal engagement/contact (either face-to-face or in a physical group) and 
wished that organisations were open again. Others preferred one to one contact, but this could 
be personal, online or by phone. One person hoped that the online meetings would continue 
after lockdown while another person said they had declined online meetings. No single form 
of contact emerged as preferable. Neither was there any general link between age and 
preference for form of contact. These are a sample of the suggestions made for continuing 
access to services:  
Set up small group meetings. Maybe use larger rooms using masks. (Female, aged 
63) 
That online meetings could be continued after lockdown. (Male, aged 47) 
The ASCERT survey highlighted similar findings about clients expressing difficulties accessing 
mental health and primary care services and continued contact with substance use services 
as significant forms of support for coping better (see ASCERT, 2020).  
Diary entries 
 
As explained above, five NIADA organisational leads agreed to maintain a diary over this time, 
noting their observations, thoughts on whether and how Covid-19 was affecting people’s drug 
and alcohol use and noting anything of concern/interest/change in patterns of use. To avoid 
placing additional work burdens on organisations, diaries were deliberately short and concise, 
with people recording their reflections in the way that suited them best. The diaries revealed 
the emergence of some common themes and patterns across the various organisations which 
both strengthen the survey findings and provide an additional perspective on substance use 
related experiences of individuals, their families and services providers during a period of 
lockdown.  
Increased demand 
All organisations recorded increased demand on their services and additional pressure on 
available resources. In terms of drug and alcohol use, much of the demand was driven by an 
upturn in the number of clients relapsing and the subsequent increased intensity required to 
re-engage with clients, just to get them back to their original starting point. For older clients, 
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increased demand was observed by an increase in the number of re-referrals from other 
agencies/sources. This required a doubling of efforts by the organisational team, simply to re-
establish the status quo. 
As reported in the EMCDDA 2020 study, decreasing substance use was also noticed in the 
earlier weeks of this research gathering exercise. However, higher incidents of relapse, 
particularly among younger clients, were recorded in the later weeks. Higher rates of Covid-
19 infections in the general public during the earlier weeks were thought to have helped act 
as a deterrent against high-risk drug and alcohol use. There was a suggestion that clients 
(mostly younger clients) were more wary of overdosing, which might increase their risk of 
hospital admission and, consequently (they believed) increase their risk of exposure to 
infection of Covid-19. However, once infection rates in the community began to decrease, the 
fear of risk of infection in this way diminished, stimulating more dangerous usage, which 
brought with it increased risks of relapse. Relapse is expected, particularly when dealing with 
new circumstances or when circumstances are out of a person’s control and is recognised as 
part of the recovery cycle. The need to deal with relapse and prevent clients becoming 
disengaged or ‘harder to reach’ became a fundamental concern for staff. 
For some particularly vulnerable clients (e.g. among homeless heroin users), higher rates of 
Covid-19 infection among the public during the earlier days of lockdown were thought to have 
helped reduce regular substance use. However, the stimulus for change was different, with 
an empty city centre diminishing a source of income. One organisation noted a heightened 
risk of withdrawal symptoms and a loss of tolerance among this population.  
For many clients, existing issues (e.g. poor mental and physical health) were noticeably more 
intensified and complex. Feelings of isolation and loneliness were major contributing factors 
for deteriorating mental health including depression and anxiety and other co morbid 
conditions. Some clients who were shielding due to serious physical health conditions had 
heightened fears and anxiety regarding their risk of contracting Covid-19, exacerbating co-
existing emotional and mental health issues.   
The observed increase in deteriorating mental health is in line with recent studies suggesting 
that pre-existing mental health conditions could have been exacerbated by lockdown and 
concerns about COVID-19 (Chatterjee et al., 2020; WHO, 2020). Factors causing concern 
were similar as those found here and included loneliness, fear of contracting the virus and 
worry about vulnerable family members or close friends.  
This type of complex demand had a ‘ripple effect’ manifesting in concurrent and increasing 
demand in the number of client families requesting help. Organisations offering family support 
reported a greater uptake of family services and increasing numbers of unscheduled family 
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support during this time. Depression, anxiety and helplessness, heightened by feelings of 
isolation, were also common experiences among families who turned to the organisations for 
help, irrespective of whether their family member was receiving treatment or not. 
Observations on usage 
In terms of usage, a number of organisations observed that cannabis appeared more difficult 
to obtain. The general sense was that available supply was becoming more expensive and 
was of dubious quality. An increase in the use of substituting one substance with another was 
a pattern noted by staff. For instance, a rise in the use of prescription medication and cocaine 
was noted by more than one organisation, a pattern echoed in the ASCERT 2020 survey 
findings and in the EMCDDA 2020 study. While not a common observation, there was a slight 
increase noticed in changing routes of opioid usage – where a small number of clients had 
moved from swallowing or inhaling towards injecting, and in the case of the ASCERT survey 
findings, with increased incidence of groin injecting reported by some organisations.  
A few organisations noted a growing number of incidents of the emergence of non-prescribed 
and ‘fake’ Benzodiazepines, particularly visible among those in temporary accommodation. 
One organisation had sent pills off for testing, all of which came back positive for 
Flualprazolam content, raising concern due to the higher potency, the increasing availability 
of this compound in UK markets and its involvement with 12 flualprazolam-associated deaths 
in the UK reported in March 2020 (ACMD, 2020).  
Some of the recorded side effects of Flualprazolam (e.g. increase in seizure, aggression, 
increased anxiety, violent behaviour, loss of impulse control, irritability and suicidal behaviour 
(ACMD, 2020)) were reported by organisational staff as being visible among clients. These 
effects were particularly noticeable in clients who were taking what they believed to be ‘blues’ 
(Diazepam) but were actually taking Flualprazolam. 
Of note here is that although the survey findings showed that 45% of people were using less 
of their main substance, the dairies suggested that this might have been a temporary feature, 
with people returning to previous patterns of use quite quickly, once Covid-19 infection rates 
began to decrease and/or once issues of supply and access were resolved. As noted by 
EMCDDA (2020), the true impact will only become evident in time. 
Mainly, demand on existing services can be viewed in terms of depth as well as breadth: Depth 
because responses to individual clients’ needs required much more intense efforts by staff to 
deal with the situation. Re-engagement for example, required time, determination and 
endurance. Problematic access to mental health and primary care services put greater strain 
on community organisations’ resources. Breadth, because some clients’ existing conditions 
became more complex. Families and the wider family circle were experiencing deeper and 
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greater levels of need because of trying to cope with their family member’s more complex 
situation. All of which added pressure on finite resources.  
Support services 
Following lockdown, support organisations had to reconfigure quickly their existing services to 
comply with Covid-19 restrictions. In place of physical contact for example, services had to 
convert to online and/or other forms of socially distanced communication. There was no 
precedent for this way of working and organisations had no way of knowing how individual 
clients might respond. Therefore, all information on client response to different methods of 
communication is beneficial for future learning. 
One common message was that keeping lines of communication open on a regular basis was 
critical. The regularity of being able to ‘check-in’ with a member of staff was of significant 
importance to clients, be that via a telephone call or a text message. Staff noted that regular 
‘check-ins’ provided a level of reassurance and, importantly, client accountability. This 







These findings are based on a short survey carried out at one point in time during an 
unparalleled health crisis. The research was in response to concerns about meeting the needs 
of clients and their families during Covid-19 restrictions, and learning about the most effective 
ways to deliver services and continue giving support that would help people cope better. 
NIADA wanted to coordinate all information that was available, with the aim of recording the 
experience for future learning.  
The questionnaire collected data at one point in time. It was very brief to cause as little burden 
as possible to respondents, particularly given already high levels of existing need and 
challenging circumstances brought about by lockdown. Although the survey was carried out 
with existing clients, it was anonymous and no unique identification code was used. Therefore, 
there is no opportunity to follow-up on the findings or make comparisons with previous data. 
This limits the amount of information that was collected and the capacity to address any other 
questions posed by the findings.  
It also raises the tension between an ideal scenario whereby individual unique identifiers are 
attributed to clients, allowing for the collection of baseline data and respondent follow-up - with 
a less ideal but practical scenario whereby research is carried out in challenging real life 
circumstances.  
However, it still provides a valuable snapshot of the experiences of people reliant on drug and 
alcohol services, and their families, during lockdown. The findings also provide some useful 
messages for future learning, particularly in light of the unpredictable nature of Covid-19 and 











The survey findings suggested that, at the time the survey was completed, a large percentage 
of people said they were using less of their main substance. However, this was a short, quick 
survey taken at one-point-in-time. Observations noted in the diaries suggest that this might 
have been only temporary, changing as the risk of infection from Covid-19 lessened and/or 
supply and access issues were resolved. Additionally, erratic usage during lockdown may 
possibly have had unforeseen consequences in terms of increasing demand due to more 
complex needs.  
The reliance on the voluntary and community sector for mental health support draws attention 
to the dual diagnosis issues of clients.  Problematic access to mental health and primary care 
services reported by respondents underlines how these issues are less likely to be address 
within primary care or acute services. It also demonstrates how lack of access to health 
services affected organisations in terms of additional demand on their services.  
Relapse is not unexpected, particularly when dealing with new circumstances or 
circumstances out of a person’s control.  Relapse is part of the recovery cycle and is 
recognised as such by substance use services.  It is not failure if, and when, dealt with in 
treatment. Organisations were constantly alert to the need to deal with such situations, 
especially during lockdown, intensifying efforts required.  
A core message was that consistent contact – in whichever form – was significant to help 
people cope and/or help them maintain stability.  
The survey and diary entries both underline the key role of the family. Family support is a pre-
requisite for ongoing recovery to ensure capacity is available within the home when 
treatment/support ends. Therefore, maintaining the ability of the family to carry on in their 
supportive role is also fundamental. 
Unique clients numbers are necessary to track and trace clients  - not only for research 
purposes but to also create coherency in terms of referral pathways, assessment, sharing of 
information, treatment/support , follow up and relapse prevention – all of which will improve 
the client experience and ultimately provide better outcomes in terms of substance use and 
mental health 
There was no unifying system of identification coding used across organisations. Adoption of 
universal processes by all substance use organisations, in tandem with primary care and acute 
services, to include unique personal identification numbers and assessment/outcome tools, 
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would greatly enhance information and knowledge. This would require additional government 
resources and investment.  
Services need to be flexible and well resourced to offer the level of engagement clients require.  
Vulnerable clients are usually dealing with chaos.  This snap shot during lockdown offers us 
the opportunity to see how chaotic behaviours manifest.  It would have been very useful to 
track and follow up on these clients post lockdown. 
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